Saturday November 18, 2017 23:10

Heathcare Press Release : 11 Sep 2017

Galderma: Combined Use of Rosacea Therapies Ivermectin 1% Cream and Brimonidine 0.33% Gel Evaluated Heathcare—11 Sep 17

Today, the results of a study evaluating the combined use of topical rosacea treatments ivermectin 1% cream and brimonidine 0.33% gel were published in the Journal of Drugs in Dermatology. (Logo: http://mma.prnewswire.com/media/554005/Galderma_Logo.jpg

Janssen to Discontinue Hepatitis C Development Program Heathcare—11 Sep 17

- Viral Hepatitis Research and Development to Focus on Addressing Significant Unmet Needs in Chronic Hepatitis B Janssen Sciences Ireland UC (Janssen), today announced a strategic decision to discontinue further development of the investigational

Merck #Grant for Oncology Innovation Awards Recognize Recipients for Pushing Boundaries in Oncology Heathcare—11 Sep 17

- EUR1 million grant funded by Merck supports research with the potential to advance implementation of personalized treatment for solid tumors - Three winners selected from 100 scientifically diverse applicants worldwide Merck, a leading science and